Larry Allen, MD, MHS, University of Colorado Anschutz Medical School.
Scott Lundgren, DO, Nebraska Medication.
FDA: “What You Required to Know (And What We’re Working to Learn) About Products Containing Marijuana or Cannabis-derived Substances, Consisting Of CBD,” “FDA Authorizes First Drug Comprised of an Active Active Ingredient Derived from Cannabis to Deal With Unusual, Extreme Kinds of Epilepsy,” “FDA and Marijuana: Research Study and Drug Approval Process.”
JCI Insight: “A single dosage of cannabidiol lowers high blood pressure in healthy volunteers in a randomized crossover research study.”
Oxidative Medication and Cellular Durability: “Healing Applications of Cannabinoids in Cardiomyopathy and Cardiac Arrest.”
Marijuana and Cannabinoid Research Study: “An Update on Security and Adverse Effects of Cannabidiol: An Evaluation of Medical Information and Appropriate Animal Research Studies.”
ClinicalTrials.gov: “Cannabidiol in Clients With Cardiac Arrest in AHA/ACC Stages A-C (CAPITAL-AC).” NCT03634189
Journal of Heart Failure: “Cannabis Usage is Related To Better Medical Facility Result in Clients with Intense Cardiac Arrest: A Tendency Match Analysis from National Inpatient Database.”